Philips expands digital pathology portfolio with cloud-enabled solution on AWS

THE NETHERLANDS—Royal Philips, a global health technology leader based in the Netherlands, has launched new cloud-enabled capabilities for its digital pathology portfolio.

The expansion aims to help healthcare organizations scale digital diagnostics, boost productivity, and transition to fully digital workflows.

The Philips IntelliSite Pathology Solution on HealthSuite runs on Amazon Web Services (AWS) infrastructure.

This fully cloud-enabled platform allows pathology laboratories to adopt and scale digital workflows without managing complex on-premise infrastructure.

The system securely stores, manages, and analyzes large volumes of high-resolution pathology images while enabling pathologists to access, review, and collaborate on cases from virtually anywhere.

Industry recognition and market challenges

The collaboration combines Philips’ digital pathology expertise with AWS’ healthcare cloud infrastructure.

Frost & Sullivan recognized Philips with the 2025 Global Enabling Technology Leadership Award in Digital Pathology in January 2026, while AWS earned the 2026 Best in KLAS designation for Public Cloud Infrastructure.

Healthcare organizations face mounting pressure to manage increasing image volumes, address workforce shortages, and prepare for AI-enabled diagnostics.

The Signify Research Digital Pathology – World 2025 report reveals that many pathology departments have not yet adopted digital pathology for routine clinical diagnosis.

These facilities continue operating hybrid environments where microscopes remain central to primary diagnosis.

Benefits of digital transformation

Fully digital workflows improve efficiency, enable collaboration and case review, enhance diagnostic consistency, and create structured data foundations that support quality improvement and scalable AI interoperability.

Philips’ cloud-enabled offering supports secure remote access to images, simplifies data management at scale, and facilitates enterprise integration and AI-enabled applications across health systems.

Dr. Cordon-Cardo, Chair of the Department of Pathology, Molecular and Cell-Based Medicine at Mount Sinai Health System, shared his perspective as an early digital pathology adopter.

He explained that as their program matures, the ability to scale efficiently across sites and manage growing pathology data volumes becomes increasingly important.

The cloud-enabled deployment reduces reliance on on-premise infrastructure while providing the flexibility, performance, and scalability required for enterprise collaboration and AI integration.

Comprehensive portfolio and vision

Philips’ digital pathology portfolio includes FDA-cleared whole-slide scanners, an image management system, archive services, and implementation support.

With thousands of users worldwide and a growing number of clinical sites going fully digital, Philips has built one of the largest installed bases.

Martijn Hartjes, Business Leader Clinical Informatics at Philips, emphasized that successful digital pathology adoption extends beyond technology.

 The company combines scalable cloud innovation with domain expertise and end-to-end services, partnering with customers throughout their transformation journey from the first digital slide to fully connected ecosystems that turn data into actionable insights for precision care.

Philips will showcase its expanded digital pathology portfolio at HIMSS 2026 in Las Vegas from March 9-12 and at USCAP 2026 in San Antonio from March 21-26.